RxDoctor Payments Data

Jenna Beardslee, APRN

Adult Health · la Crosse, WINPI 1669981288

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,691 of the $3,469 with a category attached, or 77.6%. Medtronic accounts for 79.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $1,683 and has fallen 87.2% since, to $215 in 2025. Among adult health clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,469in general payments, 2019–2025

Across 55 payments — averaging $63.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Biosense Webster, Inc.$266
  • Boston Scientific$254
  • Abbott$120
  • E.r. Squibb & Sons, L.L.C.$66
  • Johnson & Johnson$17

What the payments were for

  • Travel & lodging$77822%
  • Food & beverage$2,69178%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,469 in reported general payments places this provider in the 90th percentile of 170 adult health providers in Wisconsin.

See all adult health providers in Wisconsin

Medicare billing

Part B allowed, 2024
$55,522
Medicare patients
550
Services billed
1,224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban211$236,296
MultaqDronedarone Hcl46$52,584
XareltoRivaroxaban24$21,766
Flecainide Acetate188$9,832
Metoprolol Succinate288$5,356
Mexiletine Hcl27$5,106
Amiodarone Hcl147$2,992
Diltiazem 24hr Er (Cd)Diltiazem Hcl43$2,439
Dofetilide27$1,912
Metoprolol Tartrate79$665
SotalolSotalol Hcl15$290
Mupirocin29$136

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$17$21,76624 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 170 adult health providers in Wisconsin.

Other adult health in la Crosse

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →